Embryonic Stem Cells/Induced Pluripotent Stem Cells

You have free access to this content

Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia^†^‡^§

Kristen J. Brennand,
Fred H. Gage^¶,*

Article first published online: 16 NOV 2011

DOI: 10.1002/stem.762

Issue

STEM CELLS

Volume 29, Issue 12, pages 1915–1922, December 2011

Additional Information

How to Cite

Brennand, K. J. and Gage, F. H. (2011), Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia. STEM CELLS, 29: 1915–1922. doi: 10.1002/stem.762

Author Information

Salk Institute for Biological Studies, Laboratory of Genetics, La Jolla, CA, USA

^¶
Telephone: 858-453-4100; Fax: 858-597-0824;

Email: Fred H. Gage (gage@salk.edu)

^*Salk Institute for Biological Studies, Laboratory of Genetics, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA

^†
Author contributions: K.J.B. and F.H.G.: wrote the review together.
^‡
Disclosure of potential conflicts of interest is found at the end of this article.
^§
First published online in STEM CELLSEXPRESS October 18, 2011.
^¶
Telephone: 858-453-4100; Fax: 858-597-0824;

Publication History

Issue published online: 16 NOV 2011
Article first published online: 16 NOV 2011
Accepted manuscript online: 18 OCT 2011 03:31PM EST
Manuscript Accepted: 25 SEP 2011
Manuscript Received: 5 AUG 2011

Funded by

California Institute for Regenerative Medicine
CIRM Grant. Grant Number: RL1-00649-1
The Lookout and Mathers Foundation
the Helmsley Foundation as well as Sanofi-Aventis

ARTICLE TOOLS

View Full Article (HTML) Get PDF (960K)

REFERENCES

1
Association AP. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Press, 1994: 886.
2
Carpenter WT, Jr., Buchanan RW. Schizophrenia. New Engl J Med 1994; 330: 681–690.
3
Hannerz H, Borga P, Borritz M. Life expectancies for individuals with psychiatric diagnoses. Public Health 2001; 115: 328–337.
4
Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (Eca) Study. JAMA 1990; 264: 2511–2518.
5
Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–217.
6
Radomsky ED, Haas GL, Mann JJ et al. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry 1999; 156: 1590–1595.
7
Caldwell CB, Gottesman II. Schizophrenia—A high-risk factor for suicide: Clues to risk reduction. Suicide Life Threat Behav 1992; 22: 479–493.
8
Brennand KJ, Simone A, Jou J et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221–225.
9
Chiang CH, Su Y, Wen Z et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011; 16: 358–360.
10
Lange N, Giedd JN, Castellanos FX et al. Variability of human brain structure size: Ages 4–20 years. Psychiatry Res 1997; 74: 1–12.
11
Giedd JN, Rapoport JL. Structural MRI of pediatric brain development: What have we learned and where are we going? Neuron 2010; 67: 728–734.
12
Vita A, De Peri L, Silenzi C et al. Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006; 82: 75–88.
13
Steen RG, Mull C, McClure R et al. Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 2006; 188: 510–518.
14
Wright IC, Rabe-Hesketh S, Woodruff PW et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157: 16–25.
15
Thompson PM, Vidal C, Giedd JN et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 2001; 98: 11650–11655.
16
Ellison-Wright I, Glahn DC, Laird AR et al. The anatomy of first-episode and chronic schizophrenia: An anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008; 165: 1015–1023.
17
Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 2008; 34: 354–366.
18
Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science 2002; 298: 556–562.
19
Kubicki M, McCarley R, Westin CF et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res 2007; 41: 15–30.
20
Wexler BE, Bell MD. Cognitive remediation and vocational rehabilitation for schizophrenia. Schizophr Bull 2005; 31: 931–941.
21
Whitfield-Gabrieli S, Thermenos HW, Milanovic S et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci USA 2009; 106: 1279–1284.
22
Kessler RM, Woodward ND, Riccardi P et al. Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Biol Psychiatry 2009; 65: 1024–1031.
23
Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660–669.
24
Kane J, Honigfeld G, Singer J et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–796.
25
Klein C, Gordon J, Pollak L et al. Clozapine in Parkinson's disease psychosis: 5-year follow-up review. Clin Neuropharmacol 2003; 26: 8–11.
26
Nord M, Farde L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther 2011; 17: 97–103.
Direct Link:
27
Gray L, van den Buuse M, Scarr E et al. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: Association with N-methyl-D-aspartic acid receptor up-regulation. Int J Neuropsychopharmacol 2009; 12: 45–60.
28
Michel FJ, Trudeau LE. Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture. Neuropharmacology 2000; 39: 1536–1543.
29
Krystal JH, Karper LP, Seibyl JP et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199–214.
30
Patil ST, Zhang L, Martenyi F et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nat Med 2007; 13: 1102–1107.
31
Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry 1999; 45: 17–25.
32
Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55: 215–224.
33
Black JE, Kodish IM, Grossman AW et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry 2004; 161: 742–744.
34
Garey LJ, Ong WY, Patel TS et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65: 446–453.
35
Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65–73.
36
Meador-Woodruff JH, Healy DJ. Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 2000; 31: 288–294.
37
Cardno AG, Gottesman II. Twin studies of schizophrenia: From bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000; 97: 12–17.
Direct Link:
38
Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187–1192.
39
Ekelund J, Hovatta I, Parker A et al. Chromosome 1 loci in Finnish schizophrenia families. Human Mol Genet 2001; 10: 1611–1617.
40
Stefansson H, Sigurdsson E, Steinthorsdottir V et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Human Genet 2002; 71: 877–892.
41
Kim JW, Lee YS, Cho EY et al. Linkage and association of schizophrenia with genetic variations in the locus of neuregulin 1 in Korean population. Am J Med Genet B Neuropsychiatr Genet B 2006; 141: 281–286.
Direct Link:
42
Corvin AP, Morris DW, McGhee K et al. Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs 97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004; 9: 208–213.
43
Li T, Stefansson H, Gudfinnsson E et al. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry 2004; 9: 698–704.
44
Liu CM, Hwu HG, Fann CS et al. Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. Am J Med Genet B Neuropsychiatr Genet B 2005; 134: 79–83.
Direct Link:
45
Stefansson H, Sarginson J, Kong A et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Human Genet 2003; 72: 83–87.
46
Tang JX, Chen WY, He G et al. Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 2004; 9: 11–12.
47
Bakker SC, Hoogendoorn ML, Selten JP et al. Neuregulin 1: Genetic support for schizophrenia subtypes. Mol Psychiatry 2004; 9: 1061–1063.
48
Law AJ, Lipska BK, Weickert CS et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc Natl Acad Sci USA 2006; 103: 6747–6752.
49
Hashimoto R, Straub RE, Weickert CS et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004; 9: 299–307.
50
Chong VZ, Thompson M, Beltaifa S et al. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 2008; 100: 270–280.
51
Hakak Y, Walker JR, Li C et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746–4751.
52
Silberberg G, Darvasi A, Pinkas-Kramarski R et al. The involvement of ErbB4 with schizophrenia: Association and expression studies. Am J Med Genet B Neuropsychiatr Genet B 2006; 141: 142–148.
Direct Link:
53
Sugai T, Kawamura M, Iritani S et al. Prefrontal abnormality of schizophrenia revealed by DNA microarray: Impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 2004; 1025: 84–91.
Direct Link:
54
Shi J, Levinson DF, Duan J et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753–757.
55
Stefansson H, Ophoff RA, Steinberg S et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744–747.
56
Purcell SM, Wray NR, Stone JL et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752.
57
Huh GS, Boulanger LM, Du H et al. Functional requirement for class I MHC in CNS development and plasticity. Science 2000; 290: 2155–2159.
58
Goddard CA, Butts DA, Shatz CJ. Regulation of CNS synapses by neuronal MHC class I. Proc Natl Acad Sci USA 2007; 104: 6828–6833.
59
Boulanger LM. MHC class I in activity-dependent structural and functional plasticity. Neuron Glia Biol 2004; 1: 283–289.
60
O'Donovan MC, Craddock N, Norton N et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053–1055.
61
Gulacsi AA, Anderson SA. Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon. Nat Neurosci 2008; 11: 1383–1391.
62
Huang FL, Huang KP, Boucheron C. Long-term enrichment enhances the cognitive behavior of the aging neurogranin null mice without affecting their hippocampal LTP. Learn Mem 2007; 14: 512–519.
63
Esslinger C, Walter H, Kirsch P et al. Neural mechanisms of a genome-wide supported psychosis variant. Science 2009; 324: 605.
64
Walsh T, McClellan JM, McCarthy SE et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539–543.
65
Kirov G, Gumus D, Chen W et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Human Mol Genet 2008; 17: 458–465.
66
Mefford HC, Sharp AJ, Baker C et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. New Engl J Med 2008; 359: 1685–1699.
67
Stefansson H, Rujescu D, Cichon S et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455: 232–236.
68
International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237–241.
69
Zhang F, Gu W, Hurles ME et al. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 2009; 10: 451–481.
70
Conrad DF, Pinto D, Redon R et al. Origins and functional impact of copy number variation in the human genome. Nature 2010; 464: 704–712.
71
Li W, Zhou Y, Jentsch JD et al. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci USA 2007; 104: 18280–18285.
72
Pletnikov MV, Ayhan Y, Nikolskaia O et al. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol psychiatry 2008; 13: 173–186, 115.
73
Kvajo M, McKellar H, Arguello PA et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci USA 2008; 105: 7076–7081.
74
Kamiya A, Kubo K, Tomoda T et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005; 7: 1167–1178.
75
Duan X, Chang JH, Ge S et al. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007; 130: 1146–1158.
76
Sasaki S, Mori D, Toyo-oka K, et al. Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. Mol Cell Biol 2005; 25: 7812–7827.
77
Shu T, Ayala R, Nguyen MD et al. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 2004; 44: 263–277.
78
Millar JK, Pickard BS, Mackie S et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005; 310: 1187–1191.
79
Morris JA, Kandpal G, Ma L et al. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: Regulation and loss of interaction with mutation. Human Mol Genet 2003; 12: 1591–1608.
80
Brandon NJ, Handford EJ, Schurov I et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: Implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 2004; 25: 42–55.
81
Ozeki Y, Tomoda T, Kleiderlein J et al. Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 2003; 100: 289–294.
82
Li B, Woo RS, Mei L et al. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007; 54: 583–597.
83
Barros CS, Calabrese B, Chamero P et al. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc Natl Acad Sci USA 2009; 106: 4507–4512.
84
Lopez-Bendito G, Cautinat A, Sanchez JA et al. Tangential neuronal migration controls axon guidance: A role for neuregulin-1 in thalamocortical axon navigation. Cell 2006; 125: 127–142.
85
Krivosheya D, Tapia L, Levinson JN et al. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J Biol Chem 2008; 283: 32944–32956.
86
Pitcher GM, Beggs S, Woo RS et al. ErbB4 is a suppressor of long-term potentiation in the adult hippocampus. Neuroreport 2008; 19: 139–143.
87
Chen YJ, Zhang M, Yin DM et al. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci USA 2010; 107: 21818–21823.
88
Wen L, Lu YS, Zhu XH et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA 2010; 107: 1211–1216.
89
Ting AK, Chen Y, Wen L et al. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci 2011; 31: 15–25.
90
Fenelon K, Mukai J, Xu B et al. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc Natl Acad Sci USA 2011; 108: 4447–4452.
91
Earls LR, Bayazitov IT, Fricke RG et al. Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome. J Neurosci 2010; 30: 15843–15855.
92
Sigurdsson T, Stark KL, Karayiorgou M et al. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010; 464: 763–767.
93
Benitez-King G, Riquelme A, Ortiz-Lopez L et al. A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases. J Neurosci Methods 2011; 201: 35–45.
94
Matigian N, Abrahamsen G, Sutharsan R et al. Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech 2010; 3: 785–798.
95
Pedrosa E, Sandler V, Shah A et al. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J Neurogenet 2011; 25: 88–103.
96
Chambers SM, Fasano CA, Papapetrou EP et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275–280.
97
Ang SL. Transcriptional control of midbrain dopaminergic neuron development. Development 2006; 133: 3499–3506.
98
Watanabe K, Kamiya D, Nishiyama A et al. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci 2005; 8: 288–296.
99
Arlotta P, Molyneaux BJ, Chen J et al. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 2005; 45: 207–221.
100
Molyneaux BJ, Arlotta P, Hirata T et al. Fezl is required for the birth and specification of corticospinal motor neurons. Neuron 2005; 47: 817–831.
101
Chen B, Schaevitz LR, McConnell SK. Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc Natl Acad Sci USA 2005; 102: 17184–17189.
102
Frantz GD, Weimann JM, Levin ME et al. Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J Neurosci 1994; 14: 5725–5740.
103
Weimann JM, Zhang YA, Levin ME et al. Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets. Neuron 1999; 24: 819–831.
104
Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003; 21: 1200–1207.
105
Aubry L, Bugi A, Lefort N et al. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci USA 2008; 105: 16707–16712.
106
Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25: 4694–4705.
107
Hu BY, Du ZW, Zhang SC. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 2009; 4: 1614–1622.

View Full Article (HTML) Get PDF (960K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia^†^‡^§

STEM CELLS

How to Cite

Author Information

Publication History

Funded by

ARTICLE TOOLS

REFERENCES

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia†‡§

STEM CELLS

How to Cite

Author Information

Publication History

Funded by

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

REFERENCES

More content like this

Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia^†^‡^§